The U.S. Food and Drug Administration has cleared Medtronic PLC's Stealth Autoguide system, a robotic surgery platform that provides positioning assistance during neurosurgical procedures.
Medtronic's robotic platform helps surgeons prepare and carry out precise procedures as part of the company's Surgical Synergy platform.
Dublin-based Medtronic develops device-based medical therapies.